Shares of Health Care sector company Pfizer moved -0.2% today, and are now trading at a price of $35.55. The large-cap stock's daily volume was 2,836,411 compared to its average volume of 26,285,181. The S&P 500 index returned a 0.0% performance.
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. The company is based in New York and has 83,000 full time employees. Its market capitalization is $200,718,991,360. Pfizer currently offers its equity investors a dividend that yields 4.5% per year.
21 analysts are following Pfizer and have set target prices ranging from $35.0 to $75.0 per share. On average, they have given the company a rating of buy. At today's prices, PFE is trading -23.09% away from its average analyst target price of $46.23 per share.
The stock's 52 week high is $54.93 per share and its 52 week low is $35.35. With average free cash flows of $19.38 Billion that have been growing at an average rate of 27.0% over the last 4 years, Pfizer declining stock performance may not be reflective of the quality of its underlying business.
| Date Reported | Cash Flow from Operations ($ k) | Capital expenditures ($ k) | Free Cashflow ($ k) | YoY Growth (%) |
|---|---|---|---|---|
| 2022-12-31 | 29,267,000 | -3,236,000 | 26,031,000 | -12.85 |
| 2021-12-31 | 32,580,000 | -2,711,000 | 29,869,000 | 157.23 |
| 2020-12-31 | 14,403,000 | -2,791,000 | 11,612,000 | 16.19 |
| 2019-12-31 | 12,588,000 | -2,594,000 | 9,994,000 | n/a |
